Health Care & Life Sciences » Pharmaceuticals | Morepen Laboratories Ltd.

Morepen Laboratories Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
3,523
3,845
4,688
5,839
6,065
Cost of Goods Sold (COGS) incl. D&A
3,192
3,448
4,057
4,820
4,905
Gross Income
330
398
631
1,019
1,160
SG&A Expense
430
451
517
732
856
EBIT
115
66
101
270
304
Unusual Expense
29
-
44
-
-
Non Operating Income/Expense
148
169
173
36
37
Interest Expense
99
87
105
72
44
Pretax Income
27
23
127
235
298
Income Tax
-
1
1
-
-
Consolidated Net Income
28
21
128
235
298
Net Income
28
21
128
235
296
Net Income After Extraordinaries
57
21
128
235
296
Net Income Available to Common
33
16
128
235
296
EPS (Basic)
0.07
0.04
0.28
0.52
0.66
Basic Shares Outstanding
450
450
450
450
-
EPS (Diluted)
0.01
0.04
0.28
0.52
-
Diluted Shares Outstanding
450
450
450
450
-
EBITDA
343
321
452
609
647
Other Operating Expense
15
12
14
17
-
Non-Operating Interest Income
11
6
2
1
-
Minority Interest Expense
-
-
-
-
2
Preferred Dividends
5
5
-
-
-

About Morepen Laboratories

View Profile
Address
409, Antriksh Bhawan
New Delhi Delhi 110001
India
Employees -
Website http://www.morepen.com
Updated 09/14/2018
Morepen Laboratories Ltd. engages in the manufacture and market of bulk drugs and pharmaceutical formulations. The company was founded by K. B.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.